1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > CNS Drug News 16 NOVEMBER 2015

CNS Drug News 16 NOVEMBER 2015

  • November 2015
  • -
  • Espicom Business Intelligence
  • -
  • 16 pages

Industry Trend Analysis - Abuse-Deterrent Formulations Will Not Curb Opioid Abuse Alone
Industry Brief - NeuroDerm Modifies ND0612H/ND0612L US Development Plan In PD
Industry Trend Analysis - Early Success No Guarantee Of ANAVEX 2-73' Commercial Potential
Industry Brief - Lupin Gains US Donepezil Approval
Industry Brief - ProMIS Acquires Worldwide Licence To Collective Coordinates
Industry Trend Analysis - Avanir Will Focus On Agitation In Alzheimer's Disease Symptoms
Industry Brief - Neos Receives Cotempla CRL From FDA
Industry Trend Analysis - Encenicline Back On Course For 2016 NDA
Industry Trend Analysis - Shire Shifting Focus To Rare Diseases
Industry Brief - FDA Grants Fast Track Designation For CAM2038 Long-Acting Buprenorphine Injectables
Industry Brief - IntelGenx/RedHill Receive First European Marketing Approval For Rizaport
Industry Trend Analysis - FDA's Tentative Approval Of Xtampza ER Will Further Delay Launch
Industry Brief - Glenmark Gains Tentative Lacosamide Approval
Industry Brief - Court Delivers Palonosetron Blow To Teva
Industry Brief - FDA Grants Breakthrough Therapy Designation To Teva's SD-809 For TD
Industry Trend Analysis - Unanimous Approval Will Put Merck's Bridion Back On Track For US Indication
Industry Brief - Knight Gains Commercial Rights To Antibe's Anti-Inflammatory And Pain Drugs
Industry Brief - CNS Conferences - February 2016

Table Of Contents

CNS Drug News 16 NOVEMBER 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.